Vivos Therapeutics VVOS
NASDAQ VVOS
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vivos Therapeutics (VVOS) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Vivos Therapeutics' Return on Capital Employed [ROCE] came in at -536.47% for Q2 2026, down 420.10 percentage points from -116.37% a year earlier and down 220.91 percentage points from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Vivos Therapeutics' Return on Capital Employed [ROCE] was -928.76%, down 789.63 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -788.73 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -139.13% in FY2024 (+211.27 pp), -350.41% in FY2023 (-202.22 pp), -148.19% in FY2022 (-55.54 pp) and -92.65% in FY2021 (+47.38 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2021.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for three consecutive quarters, with an average year-over-year change of +51.00 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q4 2024 (a gain of 426.63 percentage points), and the weakest in Q2 2026 (a drop of 420.10 percentage points).
  • Business Quant data shows VVOS's Return on Capital Employed [ROCE] at -315.56% (Q1 2026), -271.77% (Q4 2025) and -88.70% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 8.30%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 7.98%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 6.42%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 18.58%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 8.34%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 13.69%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 10.83%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 11.99%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 6.00%
10 Vivos Therapeutics 2.18 Mn -7.03 Mn 2.95 Mn -536.47%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -536.47%
Mar 31, 2026 -315.56%
Dec 31, 2025 -271.77%
Sep 30, 2025 -88.70%
Jun 30, 2025 -116.37%
Mar 31, 2025 -131.73%
Dec 31, 2024 -108.07%
Sep 30, 2024 -119.40%
Jun 30, 2024 -187.94%
Mar 31, 2024 -502.82%
Dec 31, 2023 -534.70%
Sep 30, 2023 -395.09%
Jun 30, 2023 -300.55%
Mar 31, 2023 -315.25%
Dec 31, 2022 -271.15%
Sep 30, 2022 -171.30%
Jun 30, 2022 -130.81%
Mar 31, 2022 -93.22%
Dec 31, 2021 -68.28%
Sep 30, 2021 -54.29%
API Access

Vivos Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VVOS&period=max&api_key=YOUR_API_KEY